Table 2 Calculated physicochemical and pharmacokinetic properties of the synthesized compounds.

From: New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agents

Comp

Mol. Wt

No. of HBD

No. of HBA

log P

PSA

No. of rotatable bonds

% Absorp-tion (human)

BBB perme-ability (logBB)

Metabolizedby

Total clearance log(ml/min/kg)

5

459.46

2

7

3.77

100.37

5

89.93

−1.30

CYP3A4

0.158

22

425.91

2

7

3.59

99.42

5

88.59

−1.02

CYP3A4

0.079

23

421.49

2

8

3.20

107.71

6

86.29

−0.97

CYP3A4

0.313

24

391.46

2

7

2.95

97.59

5

86.93

−0.84

CYP3A4

0.138

25

506.51

2

8

5.33

106.26

6

78.15

−1.54

CYP3A4

0.195

26

472.96

2

8

4.83

106.27

6

100.00

−1.26

CYP3A4

0.117

27

468.54

2

8

4.42

114.55

7

100.00

−1.31

CYP3A4

0.351

28

438.51

2

8

4.42

104.43

6

100.00

−1.08

CYP3A4

0.176

29

486.48

0

7

4.68

76.81

3

100.00

−1.57

CYP3A4

0.150

30

452.93

0

8

4.17

76.82

3

100.00

−0.89

CYP3A4

0.067

31

448.51

0

8

3.72

85.10

4

100.00

−1.32

CYP3A4

0.302

32

418.48

0

7

3.66

76.83

3

100.00

−1.10

CYP3A4

0.133

33

500.51

2

8

3.73

96.27

4

71.62

−1.72

CYP3A4

0.032

34

466.96

2

8

3.25

96.28

4

81.62

−1.44

CYP3A4

0.046

35

462.54

2

9

2.85

104.57

5

79.30

−1.09

CYP3A4

0.174

36

432.51

2

8

2.77

96.29

4

78.80

−0.87

CYP3A4

0.009

42

459.50

2

6

5.04

75.23

7

91.35

−0.95

CYP3A4

0.151

43

425.93

2

6

4.33

75.33

7

100.00

−0.68

CYP3A4

0.094

44

421.53

2

7

4.17

81.92

8

100.00

−0.74

CYP3A4

0.319

45

391.50

2

6

4.07

75.22

7

100.00

−0.52

CYP3A4

0.153

46

506.56

2

7

6.31

81.73

8

89.36

−1.25

CYP3A4

0.160

47

473.00

2

7

5.82

81.73

8

100.00

−0.98

CYP3A4

0.103

48

468.58

2

8

5.47

87.55

9

100.00

−1.04

CYP3A4

0.328

49

438.56

2

7

5.34

80.52

8

95.59

−0.81

CYP3A4

0.162

Rimonabant

463.79

1

5

6.11

53.32

2

100.00

0.23

CYP3A4

0.156